Hanover Insurance
THG NYSE Property & Casualty Insurance Financials FY2016βFY2025
Hanover Insurance's revenue rose 5.7% to $6.6 billion in fiscal 2025. Its operating margin was 14.2%, up from 10.4% a year earlier. Free cash flow was $1.2 billion, up 47.0%. It paid out $260 million in dividends and buybacks, 22% of free cash flow. The diluted share count rose 0.3%.
What Hanover Insurance does
No business description yet.
- Legal name
- HANOVER INSURANCE GROUP, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-060983
0000944695
Revenue and margins
Hanover Insurance had $6.6B of revenue in fiscal 2025, up 5.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 19.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2025, 17.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hanover Insurance returned $260M to shareholders in fiscal 2025, 22% of free cash flow. The diluted share count rose 0.3%.
Value Hanover Insurance yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$95.6M and divides by 36.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 11.4x Β· peers 10.1x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Hanover Insurance can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $231M | $305M | $316M | $436M | $1.1B |
| Debt incl. finance leases | β | β | $783M | $784M | $1.2B |
| Net debt / EBITDA | β | β | 4.2x | 0.5x | 0.1x |
| Debt / equity | β | β | 0.3x | 0.3x | 0.3x |
| Interest coverage | 12.7x | 8.4x | 3.1x | 19.1x | 21.6x |
| Total assets | $14.3B | $14.0B | $14.6B | $15.3B | $16.9B |
| Total liabilities | $11.1B | $11.7B | $12.1B | $12.4B | $13.4B |
| Shareholders' equity | $3.1B | $2.3B | $2.5B | $2.8B | $3.6B |
| Net debt (β = net cash) | β | β | $467M | $349M | $95.6M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$10.5M
7 insiders
Of sales under plans
43%
$4.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Dennis Francis KerriganExecutive Vice President | Sold plan | 2,104 | $222.41 | $0.5M | Form 4 |
| Aug 19, 2026 | Dennis Francis KerriganExecutive Vice President | Sold plan | 6,551 | $220.79 | $1.4M | Form 4 |
| Aug 6, 2026 | Theodore H Bunting JRDirector | Sold | 600 | $230.20 | $0.1M | Form 4 |
| Aug 5, 2026 | Theodore H Bunting JRDirector | Sold | 600 | $228.03 | $0.1M | Form 4 |
| Aug 3, 2026 | Jane D CarlinDirector | Sold | 1,000 | $231.50 | $0.2M | Form 4 |
| Jun 3, 2026 | Bryan J SalvatoreExecutive Vice President | Sold | 16,394 | $185.76 | $3.0M | Form 4 |
| May 21, 2026 | Francisco AristeguietaDirector | Sold | 1,000 | $195.37 | $0.2M | Form 4 |
| May 20, 2026 | Dennis Francis KerriganExecutive Vice President | Sold | 6,262 | $192.99 | $1.2M | Form 4 |
| May 20, 2026 | John C RochePresident and CEO, Director | Sold plan | 8,358 | $193.74 | $1.6M | Form 4 |
| May 18, 2026 | John C RochePresident and CEO, Director | Sold plan | 5,251 | $198.06 | $1.0M | Form 4 |
| May 14, 2026 | Denise LowsleyExecutive Vice President | Sold | 4,175 | $191.73 | $0.8M | Form 4 |
| May 8, 2026 | Denise LowsleyExecutive Vice President | Sold | 1,062 | $188.43 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β2.3% | β2.6% | β3.2% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Hanover Insurance THG | $8.5B | 5.7% | 14.2% | 17.8% | 21.3% | 11.4x | β | |
| Selective Insurance Group SIGI | $5.8B | 9.8% | β | 22.4% | 14.6% | 11.6x | β | Compare β |
| Old Republic International ORI | $9.6B | 11.0% | β | β | β | 8.5x | β | Compare β |
| Cincinnati Financial CINF | $27.4B | 11.4% | β | 24.5% | 17.1% | 8.3x | β | Compare β |
| Fidelity National Financial FNF | $10.8B | 5.6% | β | β | β | 14.0x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.1B | $4.3B | $4.5B | $4.9B | $4.8B | $5.2B | $5.5B | $6.0B | $6.2B | $6.6B |
| Operating income | $193M | $327M | $407M | $454M | $485M | $432M | $285M | $106M | $650M | $933M |
| Interest expense | $51.4M | $45.2M | $45.1M | $37.5M | $37.1M | $34.0M | $34.1M | $34.1M | $34.1M | $43.2M |
| Pretax income | $66.0M | $293M | $283M | $522M | $445M | $521M | $144M | $41.1M | $538M | $844M |
| Income tax | β$1.0M | $76.8M | $43.5M | $93.1M | $82.8M | $101M | $27.2M | $7.6M | $113M | $183M |
| Net income | $155M | $186M | $391M | $425M | $359M | $423M | $116M | $35.3M | $426M | $663M |
| Diluted EPS | $3.59 | $4.33 | $9.09 | $10.46 | $9.42 | $11.60 | $3.21 | $0.98 | $11.70 | $18.16 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $743M | $705M | $551M | $603M | $708M | $824M | $722M | $362M | $806M | $1.2B |
| Capital expenditure | $15.7M | $18.6M | $13.1M | $13.3M | $14.9M | $8.0M | $17.8M | $11.9M | $10.2M | $7.7M |
| Free cash flow | $728M | $686M | $538M | $590M | $693M | $816M | $705M | $350M | $796M | $1.2B |
| Depreciation and amortization | $30.7M | $30.1M | $24.6M | $21.6M | $18.2M | $16.9M | $12.9M | $6.3M | $1.5M | β$4.6M |
| Stock-based compensation | $12.0M | $12.3M | $13.4M | $17.4M | $20.1M | $22.9M | $29.0M | $31.1M | $31.0M | $35.6M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $106M | $37.2M | $57.7M | $564M | $213M | $163M | $30.8M | $0.0M | $26.7M | $129M |
| Dividends paid | $80.4M | $86.8M | $94.3M | $386M | $99.5M | $102M | $109M | $117M | $124M | $131M |
| Dividends and buybacks | $186M | $124M | $152M | $950M | $312M | $265M | $140M | $117M | $151M | $260M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $283M | $298M | $1.0B | $216M | $121M | $231M | $305M | $316M | $436M | $1.1B |
| Total debt | $786M | $787M | $778M | $653M | β | β | β | $783M | $784M | $1.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $14.2B | $15.5B | $12.4B | $12.5B | $13.4B | $14.3B | $14.0B | $14.6B | $15.3B | $16.9B |
| Total liabilities | $11.4B | $12.5B | $9.4B | $9.6B | $10.2B | $11.1B | $11.7B | $12.1B | $12.4B | $13.4B |
| Shareholders' equity | $2.9B | $3.0B | $3.0B | $2.9B | $3.2B | $3.1B | $2.3B | $2.5B | $2.8B | $3.6B |
| Margins | ||||||||||
| Operating margin | 4.8% | 7.7% | 9.0% | 9.3% | 10.1% | 8.3% | 5.2% | 1.8% | 10.4% | 14.2% |
| EBITDA margin | 5.5% | 8.4% | 9.6% | 9.7% | 10.4% | 8.6% | 5.5% | 1.9% | 10.5% | 14.1% |
| Net margin | 3.8% | 4.4% | 8.7% | 8.7% | 7.4% | 8.1% | 2.1% | 0.6% | 6.8% | 10.1% |
| FCF margin | 18.0% | 16.1% | 12.0% | 12.1% | 14.4% | 15.6% | 12.9% | 5.8% | 12.8% | 17.8% |
| Returns | ||||||||||
| Return on capital | 5.8% | 7.1% | 11.1% | 12.3% | β | β | β | β | 16.8% | 21.3% |
| Return on equity | 5.4% | 6.4% | 13.1% | 14.5% | 11.7% | 13.3% | 4.2% | 1.5% | 16.1% | 20.7% |
| Return on assets | 1.1% | 1.3% | 2.8% | 3.4% | 2.8% | 3.1% | 0.8% | 0.3% | 2.9% | 4.1% |
| Growth | ||||||||||
| Revenue growth | β19.5% | 5.3% | 5.3% | 8.8% | β1.4% | 8.4% | 4.6% | 9.6% | 4.1% | 5.7% |
| Net income growth | β53.2% | 20.1% | 110.0% | 8.7% | β15.6% | 17.9% | β72.6% | β69.6% | 1,106.8% | 55.5% |
| EPS growth | β51.5% | 20.6% | 109.9% | 15.1% | β9.9% | 23.1% | β72.3% | β69.5% | 1,093.9% | 55.2% |
| FCF growth | 71.1% | β5.7% | β21.6% | 9.6% | 17.5% | 17.8% | β13.6% | β50.4% | 127.6% | 47.0% |
| Share count change | β3.6% | β0.5% | 0.0% | β5.6% | β6.2% | β4.5% | β0.8% | 0.0% | 0.8% | 0.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.3x | 1.4x | β0.6x | 0.9x | β | β | β | 4.2x | 0.5x | 0.1x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.2x | β | β | β | 0.3x | 0.3x | 0.3x |
| Interest coverage | 3.8x | 7.2x | 9.0x | 12.1x | 13.1x | 12.7x | 8.4x | 3.1x | 19.1x | 21.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.2% | 0.3% | 0.2% | 0.2% | 0.1% |
| Stock comp / revenue | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.5% | 0.5% | 0.5% | 0.5% |
| Payouts / FCF | 25.6% | 18.1% | 28.2% | 161.1% | 45.1% | 32.5% | 19.8% | 33.5% | 18.9% | 22.2% |
| Quality scores | ||||||||||
| Accruals ratio | β4.2% | β3.5% | β1.2% | β1.4% | β2.7% | β2.9% | β4.3% | β2.3% | β2.6% | β3.2% |
Source: SEC EDGAR XBRL filings (CIK 0000944695). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.